Isolated orofacial dyskinesia: A methylphenidate-induced movement disorder

Pediatric Neurology

Volumn 27, Issue 3, 2002, Pages 224-226

  Senecky, Yehuda ^a   Lobel, Danielle ^a   Diamond, Gary W ^a   Weitz, Raphael ^a   Inbar, Dov ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CLINICAL EXAMINATION; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; OROFACIAL DYSKINESIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOLOGIC TEST;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; METHYLPHENIDATE; NEUROLOGIC EXAMINATION;

EID: 0036710110     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(02)00429-0     Document Type: Article

References (15)

1. Swanson J.M., Lerner M., Williams L. More frequent diagnosis of attention deficit-hyperactivity disorder. N Engl J Med. 333:1995;944.
2. Cyr M., Brown C.S. Current drug therapy recommendation for the treatment of attention deficit hyperactivity disorder. Drugs. 56:1998;215-223.
3. Kimko H.C., Cross J.T., Abernethy D.R. Pharmacokinetics and clinical effectiveness of methylphenidate. Clin Pharmacokinet. 37:1999;457-470.
4. Fern D., Jarman F., Barker M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder A double blind, crossover trial . Pediatrics. 100:1997;662-666.
5. Gay C.T., Ryan S.G. Paroxysmal kinesigenic dystonia after methylphenidate administration. J Child Neurol. 9:1994;45-46.
6. Lucas A.R., Weiss M. Methylphenidate hallucinosis. JAMA. 217:1971;1079-1081.
7. Lipkin P.H., Goldstein I.J., Adesman A.R. Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder. Arch Pediatr Adolesc Med. 148:1994;859-861.
8. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder A review and integration . Behav Brain Res. 94:1998;127-152.
9. Rosenberg D., Holttum J., Gershon S. Textbook of pharmacotherapy for child and adolescent psychiatric disorders Antipsychotic agents . 1994;211-216 Brunner/Mazel, New York.
10. Olanow C.W., Obeso J.A. Preventing levodopa-induced dyskinesias. Ann Neurol. 47:(4 Suppl 1):2000;S167-176. discussion S176-8.
11. Weiner W.J., Nausieda P.A., Klawans H.L. Methylphenidate-induced chorea Case report and pharmacologic implications . Neurology. 28:1978;1041-1044.
12. Gerlach J., Bjorndal N., Christensson E. Methylphenidate, apomorphine, THIP, and diazepam in monkeys Dopamine-GABA behavior related to psychoses and tardive dyskinesia . Psychopharmacology. 82:1984;131-134.
13. Denckla M.B., Bemporad J.R., MacKay M.C. Tics following methylphenidate administration A report of 20 cases . JAMA. 235:1976;1349-1351.
14. Golden G.S. The effect of central nervous system stimulants on Tourette syndrome. Ann Neurol. 2:1977;69-70.
15. Shaywitz B.A., Fletcher J.M., Shaywitz S.E. Attention-deficit/hyperactivity disorder. Adv Pediatr. 44:1997;331-367.